Overview
In a changing and expanding world, this is still the only forum designed for QPPVs by QPPVs, now in its 15th year and still going strong.
2021 Focus: The Evolution of QPPVThe QPPV Forum focuses on international QPs’ role and gives a high-level approach to the discussed topics and continues to identify key trends requiring QPPV awareness, input and oversight. This year’s objectives are built on past successes and have been shaped by valuable feedback provided by participants of the past fourteen meetings, plus many years of QPPV and Regulator interaction at this Forum. Moreover, we are looking forward to receiving information and discuss pragmatic approaches on the modern technology and how this will impact the QPPV Role.
Featured Topics
- The Role of QPPV: Evolution and Future Challenges/Expectations
- Learnings from COVID-19 Pandemic: QPPV Role and Involvement
- QPPV Requirements and Expectations in Non-EU Countries
- QPPV Oversight: Interaction between QPPV and local QPPVs, Non-EU QPPV
- UK Pharmacovigilance Requirements Post-EU Exit: Where are we now?”
- QPPV Talks
Learning Objectives
- Hear the latest updates and hot topics relating to the role of the QPPV
- Explore long term PV visions, future directions of the ‘PV world’, and potential impact on the role of the QPPV
- Network with colleagues and meet regulators
- Learn from and share experience and ideas with like-minded QPPVs in a neutral environment
- Better understand regulatory and inspectorate expectations globally
- Examine current challenges and share potential solutions
90 percent of previous participants found the forum relevant for their work. Here is why:
“A great platform of learning and exchanging the knowledge. All speakers of DIA trainings are highly experienced and they share their practical experiences which makes this event excellent. Thank you.” Phanindra Singh, 4C Pharma Solutions
An Event Designed With the QPPV Community
Featured
Short Course or Primer
-
Nov 02, 2021
Pre-conference Workshop: Introduction to the Role of QPPVs
Learn more
Who should attend?
- Global QPPVs/ Deputies
- Regulators
- Pharmacovigilance Consultants
- Directors of Pharmacovigilance Oversight and Standards
- Drug Safety Managers/Leaders
- Auditors
- Medical and Regulatory Affairs Experts
- Aspiring PV Specialists/QPPVs
Program Committee
-
Willemijn van der Spuij, MSc • Executive Director, WorldWide Patient Safety International, Europe
Bristol Myers Squibb, Switzerland -
Angela Van Der Salm, PhD, MSc • Director PV, Managing partner
DADA Consultancy B.V., Netherlands -
Shahinaz Badr • Pharmacovigilance Consultant and PVQA Auditor - EMEA
Pharma Quality Europe, United Arab Emirates -
Vicki Edwards, RPh • Vice President, Pharmacovigilance Excellence and International QPPV
AbbVie, United Kingdom -
Gemma Jimenez Sese • Patient Safety Director, EU QPPV
Almirall, S.A., Spain -
Maarten Lagendijk, MSc • Deputy EU QPPV
MSD, Netherlands -
Elspeth McIntosh, MBA, RN • Director
Castle Pharmacovigilance Ltd, United Kingdom -
Katarzyna Swiderek, MPharm, RPh • Director, Safety Evaluation Risk Management (SERM)
GlaxoSmithKline, Poland -
Kiernan Trevett, MSc • Principal Quality Lead, PDQ Quality Assurance Process GVP
Roche, United Kingdom -
Nicolas Tsiakkas, MD • Scientific Director
Medwork Pharma Research & Consulting, Greece -
Anja Van Haren, MSc • EudraVigilance Coordinator
Medicines Evaluation Board (MEB), Netherlands -
Magnus Ysander, MD • EU & UK QPPV & Head Pharmacovigilance Excellence
AstraZeneca, Sweden
Contact us
Send Email
+41 61 225 51 51
Preconference Workshop
Introduction to the Role of QPPVs
Related events
Advanced Virtual Live Workshop: QPPV Tool Box - Your Key to Success
